Carolina Angel Network
VC Fund
Carolina Angel Network is a VC fund focused on Health Care and Pharmaceutical. Carolina Angel Network provides an angel investing platform and co-investment fund that leverages the UNC alumni network.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Carolina Angel Network invests in
Health CarePharmaceuticalMedicalTherapeuticsBiotechnology
Stages Carolina Angel Network invests in
SeedSeries AVenture - Series UnknownSeries CFunding Round
Countries Carolina Angel Network invests in
United States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jon West
|
|||
2 more contacts available
Investment Focus
Industry
- Health Care 4 (29%)
- Pharmaceutical 4 (29%)
- Medical 3 (21%)
- Therapeutics 2 (14%)
- Biotechnology 2 (14%)
Stage
- Seed 5 (36%)
- Series A 5 (36%)
- Venture - Series Unknown 2 (14%)
- Series C 1 (7%)
- Funding Round 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Greg Vassie
Angel Investor
|
Angel Investor | Total investments: 1 | Find email | |
Jan Davis
Angel Investor
|
Angel Investor | Total investments: 1 | Find email | |
|
Jon West
Investor
|
Investor | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Medicom Technologies
|
Medicom provides a platform for secure exchange and use of medical imaging data in clinical and research settings. The company offers solutions that automate the retrieval, sharing, and integration of imaging studies into electronic health records, helping care teams access complete patient information without manual processes.Its platformincludes tools for interoperable data exchange, workflow automation, and de-identification of imaging data for research and analytics. These capabilities support both clinical operations and the creation of structured datasets for research, including applications in artificial intelligence and medical studies.Medicom also develops technologies that enable secure, peer-to-peer data sharing and centralized visibility across distributed healthcare systems, improving coordination between providers and supporting data-driven healthcare workflows. | Venture - Series Unknown / Jul 25, 2024 | |
Pryon
|
Pryon is an artificial intelligence company focused on enterprise knowledge management. Its natural language processing platform transforms unstructured data into experiences that increase productivity with unmatched accuracy and speed. Pryon’s automated machine learning engines deliver rapid time to value by enriching existing content. Thisno-code approach prevents operational disruption and allows organizations to quickly maximize the business value trapped within their information assets. Pryon was founded by Igor Jablokov, whose previous company defined the state of the art for AI assistants and was acquired by Amazon to form the basis for Alexa. | $19.6M / Venture - Series Unknown / Jan 11, 2023 | |
Gemelli Biotech
|
Gemelli is a biotechnology company that specializes in the microbiome, and IBS diagnostics. It strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. The company is driven by its mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringingbiotechnology innovations to market in a fiscally responsible and socially conscious way. The company was founded in 2018 and headquartered in North Carolina, United States. | $19M / Series A / Jun 22, 2022 | |
SWIR Vision Systems
|
SWIR Vision Systems is in the infrared imaging (IR) business. We have now commercialized the worlds highest resolution IR sensors and cameras globally into the industrial automation and machine vision markets. Our Acuros brand quantum-dot semiconductor technology delivers the highest clarity IR images at the lowest cost. The technology is builtupon low cost CMOS wafers, so is scalable for use as 3D depth sensors for AR/VR based consumer electronics and autonomous vehicle sensing applications. | $5M / Series A / Oct 19, 2021 | |
Revibe Technologies
|
FokusLabs is focused on creating next generation, wearable devices to help individuals with specialized needs overcome everyday obstacles. FokusLabs helps to level the playing field for these individuals by leveraging cutting-edge haptic technology to increase focus, learning and productivity.FokusLabs' first product is a best-sellingwearable, called, "RE-vibe", which increases time spent on-task by leveraging smart vibration technology through proprietary, research-based algorithms. | $3M / Apr 15, 2021 | |
|
Revibe Technologies
|
FokusLabs is focused on creating next generation, wearable devices to help individuals with specialized needs overcome everyday obstacles. FokusLabs helps to level the playing field for these individuals by leveraging cutting-edge haptic technology to increase focus, learning and productivity.FokusLabs' first product is a best-sellingwearable, called, "RE-vibe", which increases time spent on-task by leveraging smart vibration technology through proprietary, research-based algorithms. | $3M / Seed / Apr 15, 2021 | |
EternaTear
|
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.Dry eye is the inability of the tear film and lids to protect the surface of the eye, resulting in itching, burning, and pain. With a dozen or more underlying causes, dry eye is notoriously difficult to diagnose and treat, and if left untreated, it can leadto permanent corneal damage. Patients with even moderate dry eye can suffer from debilitating symptoms that lead to a drastically reduced quality of life. Current treatment options are limited, and most patients rely on over-the-counter eye drops for temporary relief. But because they neither treat the root cause nor appropriately address the symptoms, current products on the market fail to provide adequate relief and must be reapplied as often as 6-12 times every day.By pairing proven technologies with pioneering research, EternaTear™ is developing a product that is closest to natural tears. Using a previously unrecognized mechanism, EternaTear™ can remain on the eye for an extended period of time, reducing the number of applications per day and giving Dry Eye patients lasting relief. | $4.9M / Series A / Oct 11, 2020 | |
Looma
|
Looma exists to connect shoppers to the people and stories behind their products. Our first product, Loop™ At-Shelf Maker Stories, is a network of tablets in grocery stores that play short, human-centric films connecting producer to consumer. The data generated by Loop™ fuels our proprietary storytelling process, forming a flywheel we believe willone day power the world’s most sophisticated platform for human-centric point-of-decision video. | $2.2M / Seed / Jun 19, 2020 | |
Second Nature
|
Second Nature is a consumer goods company that specializes in providing air filters. It offers a web-based platform that enables people to purchase online its services include shipping, installation, and maintenance that helps their client to improve their indoor air quality and protect the HVAC system.The company was founded in 2012 andheadquartered in North Carolina, United States. | $16.4M / Series C / Mar 25, 2020 | |
|
Pryon
|
Pryon is an artificial intelligence company focused on enterprise knowledge management. Its natural language processing platform transforms unstructured data into experiences that increase productivity with unmatched accuracy and speed. Pryon’s automated machine learning engines deliver rapid time to value by enriching existing content. Thisno-code approach prevents operational disruption and allows organizations to quickly maximize the business value trapped within their information assets. Pryon was founded by Igor Jablokov, whose previous company defined the state of the art for AI assistants and was acquired by Amazon to form the basis for Alexa. | $4.5M / Seed / Nov 13, 2018 | |
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
Health Care VC Funds
32,370 investors
Biotech VC Funds
18,864 investors
Biotechnology VC Funds
17,016 investors
Medical VC Funds
16,214 investors
Health Care Investors in United States
21,541 investors
FAQ
What does Carolina Angel Network invest in?
Carolina Angel Network invests primarily in Health Care, Pharmaceutical and Medical startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Carolina Angel Network?
Public channels for Carolina Angel Network include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Carolina Angel Network?
The team at Carolina Angel Network includes Greg Vassie (Angel Investor), Jan Davis (Angel Investor) and Jon West (Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
